Please provide your email address to receive an email when new articles are posted on . High-dose hyperfractionated thoracic radiotherapy with concurrent chemotherapy improved outcomes for patients ...

(HealthDay)—Among patients with bone and brain metastases who died within 90 days of radiotherapy receipt, 21.6 percent received guideline-nonconcordant therapy, according to a research letter ...

Treatment time for patients with early-detected breast cancer may be reduced by one week with the use of simulated integrated boost (SIB) radiotherapy. Simultaneous integrated boost (SIB) radiotherapy ...

Radiotherapy was administered in both arms: 1.8- to 2.0-Gy/d fractions Monday to Friday for 35 to 39 fractions for a total dose of 70 Gy. The investigational arm received chemotherapy with cisplatin ...

A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University of Seville, in collaboration with the Virgen Macarena University Hospital, ...

Radiation plus targeted or immunotherapies could be beneficial for certain patients with lung cancer, and expert said at the CURE® Educated Patient® Lung Cancer Summit. Research is showing that ...

The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their ...

Low-dose radiotherapy for a slow-growing stomach lymphoma achieved near-perfect disease control with no severe toxicity, a small prospective study showed. After a 4 Gy dose of radiotherapy in two ...

Men with localized prostate cancer that is treated with radiotherapy have a small but statistically elevated risk for a second primary cancer compared with peers who do not undergo radiotherapy, a ...